期刊
CIRCULATION RESEARCH
卷 113, 期 2, 页码 167-175出版社
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1161/CIRCRESAHA.113.300689
关键词
cholesterol homeostasis; high-density lipoprotein cholesterol; insulin secretion; lipoproteins; oxidized low-density lipoprotein; type 2 diabetes mellitus
资金
- National Health and Medical Research Council of Australia (NHMRC) [586626]
- Contributing to Australian Scholarship and Science (CASS) Foundation [SM/10/3026]
- Perpetual Philanthropic Services [442]
- Victorian Operational Infrastructure Support Program
- NHMRC Fellowships
Rationale: High-density lipoprotein cholesterol elevation via cholesteryl ester transfer protein (CETP) inhibition represents a novel therapy for atherosclerosis, which also may have relevance for type 2 diabetes mellitus. Objective: The current study assessed the effects of a CETP inhibitor on postprandial insulin, ex vivo insulin secretion, and cholesterol efflux from pancreatic -cells. Methods and Results: Healthy participants received a daily dose of CETP inhibitor (n=10) or placebo (n=15) for 14 days in a randomized double-blind study. Insulin secretion and cholesterol efflux from MIN6N8 -cells were determined after incubation with treated plasma. CETP inhibition increased plasma high-density lipoprotein cholesterol, apolipoprotein AI, and postprandial insulin. MIN6N8 -cells incubated with plasma from CETP inhibitor-treated individuals (compared with placebo) exhibited an increase in both glucose-stimulated insulin secretion and cholesterol efflux over the 14-day treatment period. Conclusions: CETP inhibition increased postprandial insulin and promoted ex vivo -cell glucose-stimulated insulin secretion, potentially via enhanced -cell cholesterol efflux.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据